» Articles » PMID: 39313635

Structural Insights into CXCR4 Modulation and Oligomerization

Overview
Date 2024 Sep 23
PMID 39313635
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of the chemokine receptor CXCR4 by its chemokine ligand CXCL12 regulates diverse cellular processes. Previously reported crystal structures of CXCR4 revealed the architecture of an inactive, homodimeric receptor. However, many structural aspects of CXCR4 remain poorly understood. Here, we use cryo-electron microscopy to investigate various modes of human CXCR4 regulation. CXCL12 activates CXCR4 by inserting its N terminus deep into the CXCR4 orthosteric pocket. The binding of US Food and Drug Administration-approved antagonist AMD3100 is stabilized by electrostatic interactions with acidic residues in the seven-transmembrane-helix bundle. A potent antibody blocker, REGN7663, binds across the extracellular face of CXCR4 and inserts its complementarity-determining region H3 loop into the orthosteric pocket. Trimeric and tetrameric structures of CXCR4 reveal modes of G-protein-coupled receptor oligomerization. We show that CXCR4 adopts distinct subunit conformations in trimeric and tetrameric assemblies, highlighting how oligomerization could allosterically regulate chemokine receptor function.

Citing Articles

Higher-order transient membrane protein structures.

Zhang Y, Mazal H, Mandala V, Perez-Mitta G, Sondoghdar V, Haselwandter C Proc Natl Acad Sci U S A. 2024; 122(1):e2421275121.

PMID: 39739811 PMC: 11725870. DOI: 10.1073/pnas.2421275121.


MSA clustering enhances AF-Multimer's ability to predict conformational landscapes of protein-protein interactions.

Rustamov K, Baev A Bioinform Adv. 2024; 5(1):vbae197.

PMID: 39735576 PMC: 11671036. DOI: 10.1093/bioadv/vbae197.


Distinct Activation Mechanisms of CXCR4 and ACKR3 Revealed by Single-Molecule Analysis of their Conformational Landscapes.

Schafer C, Pauszek R, Pauszek 3rd R, Gustavsson M, Handel T, Millar D bioRxiv. 2023; .

PMID: 37961571 PMC: 10635023. DOI: 10.1101/2023.10.31.564925.

References
1.
Gusach A, Garcia-Nafria J, Tate C . New insights into GPCR coupling and dimerisation from cryo-EM structures. Curr Opin Struct Biol. 2023; 80:102574. PMC: 10423944. DOI: 10.1016/j.sbi.2023.102574. View

2.
Ma Y, Ding Y, Song X, Ma X, Li X, Zhang N . Structure-guided discovery of a single-domain antibody agonist against human apelin receptor. Sci Adv. 2020; 6(3):eaax7379. PMC: 6962038. DOI: 10.1126/sciadv.aax7379. View

3.
Peng S, Zhang X, Paul D, Kays L, Ye M, Vaillancourt P . Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies. PLoS One. 2016; 11(3):e0150585. PMC: 4782998. DOI: 10.1371/journal.pone.0150585. View

4.
Guan X, Kobilka T, Kobilka B . Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide. J Biol Chem. 1992; 267(31):21995-8. View

5.
Zhang W, Navenot J, Haribabu B, Tamamura H, Hiramatu K, Omagari A . A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists. J Biol Chem. 2002; 277(27):24515-21. DOI: 10.1074/jbc.M200889200. View